Vertex Pharmaceuticals Incorporated
VRTX · NASDAQ · USD
$511.08
+7.83 1.56%todayNot financial advice.
- Open
- 502.11
- Day range
- 502.06 - 514.90
- 52-week range
- 402.58 - 560.25
- Volume
- 830.43K
- Market cap
- 129.54B
- P/E ratio
- 29.73
- EPS
- 17.32
- Dividend yield
- 0.00%
- Beta
- 0.39
Performance
W
+0.31%
1M
−2.47%
3M
+2.60%
6M
+14.57%
YTD
+12.49%
Y
+21.89%
5Y
+183.51%
All
+11.3K%
In the news
Oct 9
Vertex Pharmaceuticals Reports Positive Interim Data for ALYFTREK in Young Children
Vertex Pharmaceuticals reports early data showing ALYFTREK may restore pancreatic function in young children, potentially expanding its patient base.
Company news
Oct 7
Vertex Pharmaceuticals to Announce Third Quarter 2026 Financial Results on November 2
Vertex Pharmaceuticals Incorporated will report its third-quarter 2026 financial results on November 2, highlighting updates on its growing therapy pipeline.
Earnings
Embed on your site
Embed docsAdd a live price card or a chart to any page. Free, no sign-up; cards refresh every minute and link back here.
<iframe src="https://stocks.freetheai.org/embed/NASDAQ-VRTX" width="340" height="170" style="border:0;max-width:100%" loading="lazy" title="Vertex Pharmaceuticals Incorporated (VRTX) - FreeTheAI Stocks"></iframe>
<p style="font-size:12px"><a href="https://stocks.freetheai.org/symbols/NASDAQ-VRTX">VRTX stock price</a> by FreeTheAI Stocks</p>